IRIS
TONIUTTO, Pierluigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 19.628
AS - Asia 7.190
EU - Europa 5.052
SA - Sud America 1.320
Continente sconosciuto - Info sul continente non disponibili 563
AF - Africa 164
OC - Oceania 6
Totale 33.923
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 19.184
SG - Singapore 3.504
CN - Cina 1.375
UA - Ucraina 1.063
BR - Brasile 1.023
DE - Germania 828
IT - Italia 788
HK - Hong Kong 709
VN - Vietnam 484
FR - Francia 451
FI - Finlandia 420
RU - Federazione Russa 364
SE - Svezia 328
TR - Turchia 245
IE - Irlanda 243
GB - Regno Unito 230
CA - Canada 210
BD - Bangladesh 185
IN - India 169
AR - Argentina 115
KR - Corea 101
MX - Messico 88
IQ - Iraq 65
PL - Polonia 58
EC - Ecuador 48
ZA - Sudafrica 47
BE - Belgio 46
JP - Giappone 43
PK - Pakistan 40
ES - Italia 39
IR - Iran 39
CO - Colombia 38
ID - Indonesia 38
NL - Olanda 37
AT - Austria 36
VE - Venezuela 29
PH - Filippine 27
PY - Paraguay 24
UZ - Uzbekistan 24
CR - Costa Rica 22
MA - Marocco 22
SA - Arabia Saudita 21
HN - Honduras 20
CL - Cile 19
EU - Europa 19
KE - Kenya 18
CZ - Repubblica Ceca 15
JM - Giamaica 15
LT - Lituania 15
AE - Emirati Arabi Uniti 13
GT - Guatemala 12
NI - Nicaragua 12
CH - Svizzera 11
DZ - Algeria 11
SV - El Salvador 11
AZ - Azerbaigian 10
EE - Estonia 10
ET - Etiopia 10
MY - Malesia 10
PE - Perù 10
PR - Porto Rico 10
EG - Egitto 9
GP - Guadalupe 9
GR - Grecia 9
TG - Togo 9
TN - Tunisia 9
TT - Trinidad e Tobago 9
NP - Nepal 8
AL - Albania 7
DO - Repubblica Dominicana 7
IL - Israele 7
JO - Giordania 7
AO - Angola 6
BO - Bolivia 6
LB - Libano 6
LV - Lettonia 6
BH - Bahrain 5
DK - Danimarca 5
HU - Ungheria 5
PA - Panama 5
PS - Palestinian Territory 5
PT - Portogallo 5
SN - Senegal 5
TW - Taiwan 5
AU - Australia 4
BA - Bosnia-Erzegovina 4
BB - Barbados 4
CW - ???statistics.table.value.countryCode.CW??? 4
HR - Croazia 4
KG - Kirghizistan 4
KW - Kuwait 4
KZ - Kazakistan 4
LK - Sri Lanka 4
OM - Oman 4
QA - Qatar 4
RO - Romania 4
SK - Slovacchia (Repubblica Slovacca) 4
UY - Uruguay 4
AM - Armenia 3
BG - Bulgaria 3
Totale 33.317
Salva come PNG Salva come JPEG
Città #
Fairfield 1.862
Woodbridge 1.801
Ashburn 1.723
Singapore 1.388
Ann Arbor 1.043
Houston 1.031
Chandler 1.002
San Jose 998
Seattle 775
Wilmington 740
Jacksonville 710
Hong Kong 705
Cambridge 637
Beijing 591
Council Bluffs 526
Dearborn 464
Boardman 349
Los Angeles 258
Lauterbourg 231
Princeton 231
Udine 231
Dublin 228
Munich 226
Izmir 175
Ho Chi Minh City 168
Helsinki 157
Dallas 136
Santa Clara 136
New York 133
Hefei 119
Buffalo 113
Hanoi 103
São Paulo 103
San Diego 93
Seoul 86
Redondo Beach 85
The Dalles 78
Ottawa 70
Milan 65
Phoenix 57
North Bergen 55
Des Moines 54
Warsaw 49
Nuremberg 48
Chicago 45
Mumbai 45
Brooklyn 41
Brussels 40
Frankfurt am Main 40
Atlanta 39
Mexico City 39
Montreal 39
Tokyo 39
Norwalk 36
Orem 35
Kunming 34
Ogden 34
Toronto 34
Shanghai 33
Rio de Janeiro 32
Baghdad 30
Falls Church 30
San Francisco 30
Denver 29
Nanjing 29
Rome 29
Washington 29
Miano 27
Da Nang 25
Guangzhou 25
Leawood 25
Chennai 22
Johannesburg 22
London 22
Stockholm 22
Dong Ket 21
Philadelphia 21
Vienna 21
Düsseldorf 20
Amsterdam 19
Columbus 19
Quito 19
Trieste 19
Tashkent 18
San Mateo 17
Augusta 16
Boston 16
Dhaka 16
Nairobi 16
San José 16
Zanjan 16
Belo Horizonte 15
Chongqing 15
Jinan 15
Manchester 15
Hangzhou 14
Lahore 14
Las Vegas 14
Naples 14
Poplar 14
Totale 21.254
Salva come PNG Salva come JPEG
Nome #
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 306
Interleukin 6 promoter polymorphisms influence the outcome of chronic hepatitis C. 273
Deficient antithrombin III activity and enhanced fibrinolysis in patients with liver disease: Evidence against a cause-effect relationship 263
Balancing donor and recipient risk factors in liver transplantation: the value of D-MELD with particular reference to HCV recipients. 250
Ombitasvir, paritaprevir, and ritonavir, with or without dasabuvir, plus ribavirin for patients with hepatitis C virus genotype 1 or 4 infection with cirrhosis (ABACUS): a prospective observational study 247
Increase of Serum aú1-Acid Glycoprotein Despite the Decline of Liver Synthetic Function in Cirrhotics with Hepatocellular Carcinoma 247
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 246
A single-center experience of late retransplantation of the liver. 242
Steatosis of the graft is a risk factor for posttransplantation biliary complications. 240
Skills and requirements of a transplant hepatologist: board certification of the Italian Association for the Study of the Liver (AISF). 224
Association between the epidermal growth factor rs4444903 G/G genotype and advanced fibrosis at a young age in chronic hepatitis C. 220
Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C 216
LONG-TERM OUTCOMES OF ORTHOTOPIC LIVER TRANSPLANTATION IN HUMAN IMMUNODEFICIENCY VIRUS-INFECTED PATIENTS AND COMPARISON WITH HUMAN IMMUNODEFICIENCY VIRUS-NEGATIVE CASES 212
Hepatitis B-core antibody positive donors in liver transplantation and their impact on graft survival: Evidence from the Liver Match cohort study 211
Management of infections in cirrhotic patients: report of a consensus conference. 208
Apolipoprotein E genotypes modulate fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases. 207
PNPLA3 rs738409 and TM6SF2 rs58542926 variants increase the risk of hepatocellular carcinoma in alcoholic cirrhosis 205
Intensity of inflammatory damage and serum lipid peroxide concentrations in liver disease 201
Favourable Outcome of Adefovir-Dipivoxil Treatment in Acute de Novo Hepatitis B After Liver Transplantation 201
Liver transplantation from old donors into HCV and non-HCV recipients 200
Early activation of interferon-stimulated genes in human liver allografts: relationship with acute rejection and histological outcome. 200
A comparison of four serum markers of fibrosis in the diagnosis of cirrhosis 197
SERUM FERRITIN AS A PREDICTOR OF TREATMENT OUTCOME IN PATIENTS WITH CHRONIC HEPATITIS C 197
Clinical and virologic response to entecavir in HBV related chronic hepatitis or cirrhosis: data from the clinical practice in a single centre cohort. 193
Degree of bile-duct dilatation in liver-transplanted patients with biliary stricture: a magnetic resonance cholangiography-based study. 192
Toll Like Receptor 4 D299G Associates with Disease Progression in Caucasian Patients with Chronic HBV Infection: Relationship with Gender. 191
Association between vitamin D receptor genetic polymorphisms and acute cellular rejection in liver-transplanted patients. 191
Changes in blood lipid composition and response to interferon treatment in chronic hepatitis C 189
Circulating intercellular adhesion molecule-1 (cICAM-1) concentration in liver disease. Relationship with cholestasis and functioning hepatic mass. 188
Serum soluble vascular-cell adhesion molecule-1 (VCAM-1) in patients with acute and chronic liver diseases 187
Pegylated versus standard interferon-alpha in antiviral regimens for post-transplant recurrent hepatitis C: Comparison of tolerability and efficacy 186
The interleukin 28B rs12979860 C/T polymorphism and serum cholesterol as predictors of fibrosis progression in patients with chronic hepatitis C and persistently normal transaminases. 185
Role of interleukin 28B rs12979860 C/T polymorphism on the histological outcome of chronic hepatitis C: relationship with gender and viral genotype. 185
Position paper of the Italian Association for the Study of the Liver (AISF): the multidisciplinary clinical approach to hepatocellular carcinoma. 185
DE NOVO TUMORS ARE A MAJOR CAUSE OF LATE MORTALITY AFTER ORTHOTOPIC LIVER TRANSPLANTATION 185
A study on role of the family and other risk factors in HCV transmission 185
Biliary strictures after liver transplantation: Role of interleukin 28B genotypes in cyclosporine treated 184
Mild sialoadenitis: a common finding in patients with hepatitis C virus infection 183
Low fibrosis progression of recurrent hepatitis C in apolipoprotein E e4 carriers: relationship with the blood lipid profile 183
Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial 182
DIFFUSION-WEIGHTED MRI IN EVALUATING LIVER FIBROSIS: A FEASIBILITY STUDY IN CIRRHOTIC PATIENTS 180
Role of AST to platelet ratio index in the detection of liver fibrosis in patients with recurrent hepatitis C after liver transplantation 179
INFLUENCE OF ANGIOTENSIN-CONVERTING ENZYME I/D GENE POLYMORPHISM ON CLINICAL AND HISTOLOGICAL CORRELATES OF CHRONIC HEPATITIS C 179
STEATOSIS OF THE HEPATIC GRAFT AS A RISK FACTOR FOR POST-TRANSPLANT BILIARY COMPLICATIONS 178
Genetic polymorphisms of vitamin D pathway predict antiviral treatment outcome in slow responder naïve patients with chronic hepatitis C. 177
Treatment of hepatitis C recurrence is less successful in female than in male liver transplant recipients. 173
Expression of the interferon-inducible proteins MxA and IFI16 in liver allografts. 173
Quality-of-life assessment before and after liver transplantation. 173
Genetic polymorphisms of interleukin-6 modulate fibrosis progression in mild chronic hepatitis C 172
Safety of conversion from twice-daily tacrolimus (Prograf) to once-daily prolonged-release tacrolimus (Advagraf) in stable liver transplant recipients 172
Survival after yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: a European evaluation. 171
Evidence for a multifactorial control of serum erythropoietin concentration in liver disease 171
Splenic Artery Syndrome as a Possible Cause of Late Onset Refractory Ascites after Liver Transplantation: Management with Proximal Splenic Artery Embolization 171
Specific issues concerning the management of patients on the waiting list and after liver transplantation 171
Anti-envelope antibodies in anti-hepatitis C virus (HCV) positive patients with and without liver disease 171
GENE POLYMORPHISM AT THE INTERLEUKIN 6 -174 G > C LOCUS AFFECTS THE OUTCOME OF CHRONIC HEPATITIS B 169
OCCULT HEPATITIS B VIRUS INFECTION IN LIVER TRANSPLANT RECIPIENTS WITH RECURRENT HEPATITIS C: RELATIONSHIP WITH DONOR AGE AND FIBROSIS PROGRESSION 168
Value of two noninvasive methods to detect progression of fibrosis among HCV carriers with normal aminotransferases 168
Weight gain after liver transplantation and the insertion/deletion polymorphism of the angiotensin-converting enzyme gene 167
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 167
Consensus conference on TIPS management: Techniques, indications, contraindications 167
Impact of magnetic resonance cholangiography in managing liver-transplanted patients: preliminary results of a clinical decision-making study 167
Thrombocytopenia of chronic liver disease corrected by erythropoietin treatment 166
Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial 165
Safety and efficacy of splenic artery embolization for portal hyperperfusion in liver transplant recipients: A 5-year experience 165
Recipient perioperative cholesterolaemia and graft cholesterol metabolism gene expression predict liver transplant outcome. 164
Acute alcoholic hepatitis and liver transplantation: Waiting for Godot 163
Hepatic release of erythropoietin induced by transarterial chemoembolization in patients with hepatocellular carcinoma. 162
Occult hepatitis B virus infection in peripheral blood mononuclear cells among treatment-naive patients with chronic lymphocytic leukemia. 162
Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C/T polymorphism in predicting antiviral response in chronic hepatitis C. 161
Prevalence and risk factors for delayed adrenal insufficiency after liver transplantation 161
Diagnostic usefulness of acute-phase protein measurement in hepatocellular carcinoma. 161
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies. 161
Factors associated with serum HCV RNA positivity in anti HCV antibody positive intravenous drug users 160
Non-specific increase of serum carbohydrate antigen 19-9 in patients with liver disease associated with increased circulating levels of adhesion molecules. 158
Recipient interleukin-28B Rs12979860 C/T polymorphism and acute cellular rejection after liver transplantation: role of the calcineurin inhibitor used. 157
HUMAN LEUKOCYTE ANTIGEN POLYMORPHISMS IN ITALIAN PRIMARY BILIARY CIRRHOSIS: A MULTICENTER STUDY OF 664 PATIENTS AND 1992 HEALTHY CONTROLS 157
Impact of apolipoprotein E genetic polymorphisms on liver disease: An essential review 157
Interleukin-6 polymorphisms and gender: relationship with the occurrence of hepatocellular carcinoma in patients with end stage liver disease 157
Reliability and reproducibility of the Edmonson grading of hepatocellular carcinoma using paired core biopsy and surgical resection specimens 156
Genetic polymorphisms of inflammatory cytokines and liver fibrosis progression due to recurrent hepatitis C. 155
Chronic sialoadenitis associated with HCV-related liver disease: differences in comparison to Sjogren syndrome 155
Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy. 154
IL-28B rs12979860 C/T allele distribution in patients with liver cirrhosis: role in the course of chronic viral hepatitis and the development of HCC. 154
Vitamin D and the risk of acute allograft rejection following human liver transplantation. 153
Carriage of the EGF rs4444903 A>G functional polymorphism associates with disease progression in chronic HBV infection. 153
Value of serum C-reactive protein measurement in the detection of hepatocellular carcinoma superimposed on liver cirrhosis 151
IgM antibody response to the hepatitis C virus core protein in intravenous drug users. 151
Predictors of endoscopic treatment outcome in the management of biliary complications after orthotopic liver transplantation 151
Sex-related influence of angiotensin-converting enzyme polymorphisms on fibrosis progression due to recurrent hepatitis C after liver transplantation 151
Carriage of HFE mutations and outcome of surgical resection for hepatocellular carcinoma in cirrhotic patients 150
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis. 150
Treatment of recurrent genotype 4 hepatitis C after liver transplantation: early virological response is predictive of sustained virological response. An AISF RECOLT-C group study. 149
Antiviral treatment of hepatitis C 149
Hepatitis B virus and lymphomagenesis: novel insights into an occult relationship. 148
Genetic polymorphism at the apolipoprotein E locus affects the outcome of chronic hepatitis B 147
Successful minimally invasive management of late portal vein thrombosis after splenectomy due to splenic artery steal syndrome following liver transplantation: a case report 147
A Multistep, Consensus-Based Approach to Organ Allocation in Liver Transplantation: Toward a "blended Principle Model" 147
Excess body weight, liver steatosis, and early fibrosis progression due to hepatitis C recurrence after liver transplantation 146
PNPLA3 gene polymorphism is associated with predisposition to and severity of alcoholic liver disease 146
Totale 18.071
Salva come PNG Salva come JPEG
Categoria #
all - tutte 128.979
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 128.979
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.519 0 0 0 110 27 104 108 97 32 278 479 284
2022/20232.254 259 167 35 304 229 580 1 174 339 25 79 62
2023/2024674 132 78 32 18 138 97 15 33 58 38 10 25
2024/20254.680 100 289 145 172 141 311 304 339 570 361 743 1.205
2025/20268.740 645 923 733 710 1.328 688 945 307 591 730 576 564
2026/20272.796 226 688 771 1.111 0 0 0 0 0 0 0 0
Totale 33.923